Boston Scientific
Boston Scientific Corporation is a global leader in the development, manufacturing, and marketing of medical devices used across various interventional medical specialties. The company focuses on less-invasive medical solutions that serve as alternatives to traditional surgery, aiming to improve patient outcomes while reducing healthcare costs. Its portfolio addresses complex conditions in cardiovascular, respiratory, digestive, oncological, neurological, and urological medicine.
Financials
Based on Q1 2026 filing
Revenue
View metricGross Profit
View metricNet Income
View metricOperating Cash Flow
View metricFree Cash Flow
View metricEPS (Diluted)
View metricBusiness Segments
Cardiovascular
primaryA newly consolidated segment that integrates cardiology and peripheral interventions to treat coronary, peripheral, and venous diseases. It includes market-leading technologies for heart rhythm management, electrophysiology, and stroke risk reduction.
WATCHMAN™, FARAPULSE™ PFA System, SYNERGY™ Stent Systems, AGENT™ Drug-Coated Balloon, RESONATE™ ICD, HeartLogic™, TheraSphere™ Y-90, Lightning Bolt™
Interventional cardiologists, Electrophysiologists, Vascular surgeons, Oncologists, Hospital networks
MedSurg
majorThis segment focuses on minimally invasive technologies for endoscopy, urology, and neuromodulation. It provides tools for diagnosing and treating gastrointestinal conditions, kidney stones, pelvic floor disorders, and chronic pain management.
Resolution 360™, SpyGlass™, AXIOS™ Stents, LithoVue™, GreenLight XPS™, Rezūm™ Systems, WaveWriter Alpha™, Intracept™, Vercise Genus™
Hospitals, Outpatient facilities, Gastroenterologists, Urologists, Neurologists
Segment Financials
Cardiovascular — Research and development expenses, percentage of net sale
View metricCardiovascular — Cost of products sold, percentage of net sale
View metricCardiovascular — Other segment items, percentage of net sale
View metricMedSurg — Research and development expenses, percentage of net sale
View metricMedSurg — Research and development expenses
View metricMedSurg — Net sales of reportable segments
View metricBusiness Overview
Competitive Position
A leading global medical technology provider specializing in category leadership through high-growth adjacencies and less-invasive procedural innovation.
Geographies
Global, United States, China, Japan, Europe
Customer Segments
Hospitals, Specialist Physicians, Ambulatory Surgery Centers, Group Purchasing Organizations
Upstream Dependencies
Raw material suppliers, Specialized component manufacturers, Sterilization service providers, Research institutions and universities
Downstream Customers
Hospitals, Clinics, Medical offices, Group Purchasing Organizations (GPOs), Third-party distributors
Competitors & Partners
Competitors
Medtronic
MDT
Diversified global medical device competitor
Stryker
SYK
Competitor in endoscopy and neurotechnology
Edwards Lifesciences
EW
Competitor in structural heart and critical care monitoring
Abbott
ABT
Competitor in cardiovascular and neuromodulation markets
Johnson & Johnson
JNJ
Competitor in surgery and interventional solutions
STERIS
STE
Healthcare segment competitor
Subsidiaries
Bolt Medical, Inc.
Developer of intravascular lithotripsy advanced laser-based platform
SoniVie Ltd.
Developer of the TIVUS™ Intravascular Ultrasound System
Penumbra
PEN
Medical technology company focused on thrombectomy products (acquisition announced)
Boston Scientific FAQ
Common questions about Boston Scientific
Boston Scientific Corporation is a global leader in the development, manufacturing, and marketing of medical devices used across various interventional medical specialties. The company focuses on less-invasive medical solutions that serve as alternatives to traditional surgery, aiming to improve patient outcomes while reducing healthcare costs. Its portfolio addresses complex conditions in cardiovascular, respiratory, digestive, oncological, neurological, and urological medicine.
Boston Scientific (BSX) has a market capitalization of $85.9B and trades on NYSE.
Boston Scientific generated $20.6B in trailing twelve-month revenue with net income of $3.6B, representing a net margin of 17.3%. Gross margin stands at 69.2%, with free cash flow of $3.5B. These figures are based on the Q1 2026 filing.
Boston Scientific's key competitors include Medtronic plc, Stryker Corporation, Edwards Lifesciences, and others. These companies compete in similar markets and product categories.
Boston Scientific has approximately 48,000 employees.